{"id":"https://openalex.org/W2602419081","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.5079","title":"Phase II trial of pemetrexed disodium and gemcitabine in advanced carcinoma of the urothelium (E4802): A trial of the Eastern Cooperative Oncology Group","display_name":"Phase II trial of pemetrexed disodium and gemcitabine in advanced carcinoma of the urothelium (E4802): A trial of the Eastern Cooperative Oncology Group","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2602419081","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.5079","mag":"2602419081"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.5079","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.5079","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.5079","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063957223","display_name":"S. Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Li","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic, Cleveland, OH; Vanderbilt -Ingram Cancer Center, Nashville, TN; University Hospitals of Cleveland, Cleveland, OH; University of Wisconsin Cancer Center, Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic, Cleveland, OH; Vanderbilt -Ingram Cancer Center, Nashville, TN; University Hospitals of Cleveland, Cleveland, OH; University of Wisconsin Cancer Center, Madison, WI","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I135310074","https://openalex.org/I2799343972","https://openalex.org/I4210103341","https://openalex.org/I4210117453","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103138544","display_name":"Robert Dreicer","orcid":"https://orcid.org/0000-0002-0552-6912","observed_orcids":["https://orcid.org/0000-0002-0552-6912"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Dreicer","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic, Cleveland, OH; Vanderbilt -Ingram Cancer Center, Nashville, TN; University Hospitals of Cleveland, Cleveland, OH; University of Wisconsin Cancer Center, Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic, Cleveland, OH; Vanderbilt -Ingram Cancer Center, Nashville, TN; University Hospitals of Cleveland, Cleveland, OH; University of Wisconsin Cancer Center, Madison, WI","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I135310074","https://openalex.org/I2799343972","https://openalex.org/I4210103341","https://openalex.org/I4210117453","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040850986","display_name":"Bruce J. Roth","orcid":"https://orcid.org/0000-0002-9333-571X","observed_orcids":["https://orcid.org/0000-0002-9333-571X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Roth","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic, Cleveland, OH; Vanderbilt -Ingram Cancer Center, Nashville, TN; University Hospitals of Cleveland, Cleveland, OH; University of Wisconsin Cancer Center, Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic, Cleveland, OH; Vanderbilt -Ingram Cancer Center, Nashville, TN; University Hospitals of Cleveland, Cleveland, OH; University of Wisconsin Cancer Center, Madison, WI","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I135310074","https://openalex.org/I2799343972","https://openalex.org/I4210103341","https://openalex.org/I4210117453","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012834136","display_name":"J. Manoloa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Manoloa","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic, Cleveland, OH; Vanderbilt -Ingram Cancer Center, Nashville, TN; University Hospitals of Cleveland, Cleveland, OH; University of Wisconsin Cancer Center, Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic, Cleveland, OH; Vanderbilt -Ingram Cancer Center, Nashville, TN; University Hospitals of Cleveland, Cleveland, OH; University of Wisconsin Cancer Center, Madison, WI","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I135310074","https://openalex.org/I2799343972","https://openalex.org/I4210103341","https://openalex.org/I4210117453","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108232407","display_name":"Matthew M. Cooney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Cooney","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic, Cleveland, OH; Vanderbilt -Ingram Cancer Center, Nashville, TN; University Hospitals of Cleveland, Cleveland, OH; University of Wisconsin Cancer Center, Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic, Cleveland, OH; Vanderbilt -Ingram Cancer Center, Nashville, TN; University Hospitals of Cleveland, Cleveland, OH; University of Wisconsin Cancer Center, Madison, WI","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I135310074","https://openalex.org/I2799343972","https://openalex.org/I4210103341","https://openalex.org/I4210117453","https://openalex.org/I4390039299"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061697254","display_name":"George Wilding","orcid":"https://orcid.org/0009-0000-5775-5293","observed_orcids":["https://orcid.org/0009-0000-5775-5293"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]},{"id":"https://openalex.org/I2799343972","display_name":"University Hospitals of Cleveland","ror":"https://ror.org/0130jk839","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972"]},{"id":"https://openalex.org/I4210103341","display_name":"University of Wisconsin Carbone Cancer Center","ror":"https://ror.org/01e4byj08","country_code":"US","type":"funder","lineage":["https://openalex.org/I135310074","https://openalex.org/I2799905417","https://openalex.org/I4210103341","https://openalex.org/I4210132596"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Wilding","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic, Cleveland, OH; Vanderbilt -Ingram Cancer Center, Nashville, TN; University Hospitals of Cleveland, Cleveland, OH; University of Wisconsin Cancer Center, Madison, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA; Cleveland Clinic, Cleveland, OH; Vanderbilt -Ingram Cancer Center, Nashville, TN; University Hospitals of Cleveland, Cleveland, OH; University of Wisconsin Cancer Center, Madison, WI","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I135310074","https://openalex.org/I2799343972","https://openalex.org/I4210103341","https://openalex.org/I4210117453","https://openalex.org/I4390039299"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"5079","last_page":"5079"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12695","display_name":"Urinary and Genital Oncology Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.8709999918937683},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.8169999718666077},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.800000011920929},{"id":"https://openalex.org/keywords/advanced-bladder-cancer","display_name":"advanced bladder cancer","score":0.6539999842643738},{"id":"https://openalex.org/keywords/antifolate-drugs","display_name":"antifolate","score":0.6470000147819519},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6930000185966492},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.7170000076293945},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.6359999775886536},{"id":"https://openalex.org/keywords/metastatic-disease","display_name":"metastatic disease","score":0.7089999914169312},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7139999866485596},{"id":"https://openalex.org/keywords/sepsis","display_name":"sepsis","score":0.43700000643730164},{"id":"https://openalex.org/keywords/cardiac-arrest","display_name":"cardiac arrest","score":0.871999979019165},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.3610000014305115},{"id":"https://openalex.org/keywords/partial-response","display_name":"partial response","score":0.8610000014305115},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.32600000500679016}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9379634261131287},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.8966569304466248},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.8059618473052979},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6372609734535217},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5848668217658997},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.559904158115387},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.5067294239997864},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.426688551902771},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.41812556982040405},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4150465726852417},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.40046244859695435},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3658061921596527},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.2702292799949646}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.5079","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.5079","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.5079","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8299999833106995,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1978619418","https://openalex.org/W2591075976","https://openalex.org/W2241325899","https://openalex.org/W2072029106","https://openalex.org/W1980050012","https://openalex.org/W2983486717","https://openalex.org/W2162202499","https://openalex.org/W2022520742","https://openalex.org/W2086361734","https://openalex.org/W2055225731"],"abstract_inverted_index":{"5079":[0],"Background:":[1],"Advanced":[2],"urothelial":[3,46,60],"carcinoma":[4],"is":[5,35,286],"a":[6,36,97,119],"moderately":[7,24],"chemosensitive":[8],"disease.":[9],"Although":[10],"the":[11,153,270,335,339],"gemcitabine/cisplatin":[12],"regimen":[13],"has":[14,292,324],"essentially":[15],"replaced":[16],"M-VAC":[17],"as":[18],"front-line":[19],"therapy,":[20],"both":[21],"regimens":[22],"are":[23],"toxic":[25],"and":[26,31,145,162,171,177,202,227,269,280,297],"produce":[27],"similar":[28],"response":[29,296,304],"rates":[30],"median":[32,208],"survival.":[33],"Pemetrexed":[34],"novel":[37],"multi-targeted":[38],"antifolate":[39],"with":[40,53,58,64,90,197,245,301,329],"single":[41],"agent":[42],"activity":[43,326],"in":[44,51,55,152,327],"advanced":[45,59,332],"cancer.":[47,61],"We":[48],"evaluated":[49],"pemetrexed":[50,70],"combination":[52],"gemcitabine":[54,79,91],"untreated":[56,331],"pts":[57,141,150,167,186,231,255,313],"Methods:":[62],"Patients":[63,108],"TCC":[65,333],"or":[66,115,118,248],"mixed":[67],"histologies":[68],"received":[69],"500":[71],"mg/m2":[72],"IV":[73,83],"over":[74,84],"10":[75,298],"minutes":[76,86],"followed":[77],"by":[78],"1,000":[80],"mg/":[81],"m2":[82],"30":[85],"on":[87,93,110],"day":[88,94],"1,":[89],"repeated":[92],"8":[95],"of":[96,121,124,185,209,306,334,341],"21-day":[98],"cycle.":[99],"Dose":[100],"reductions":[101],"were":[102,129,146,212,223],"mandated":[103],"for":[104,220,288,317],"grade":[105,233,246,258],"3/4":[106],"toxicities.":[107],"remained":[109],"treatment":[111,222],"until":[112],"disease":[113,190,225,316],"progression":[114],"unacceptable":[116],"toxicity":[117,228],"maximum":[120],"6":[122,320],"cycles":[123,211],"therapy.":[125],"Standard":[126],"RECIST":[127],"criteria":[128],"used":[130],"to":[131],"assess":[132],"response.":[133],"Results:":[134],"Total":[135],"accrual":[136],"was":[137,158,266],"46":[138],"pts.":[139,290],"Two":[140,254],"never":[142],"started":[143],"therapy":[144],"excluded,":[147],"leaving":[148],"44":[149],"included":[151],"analysis.":[154],"The":[155,216],"pt":[156,252,272],"cohort":[157],"36":[159],"(82%)":[160],"male":[161],"42":[163],"(95%)":[164],"Caucasian.":[165],"Twenty-two":[166],"(50%),":[168],"21":[169],"(48%)":[170],"1":[172,176,294],"(2%)":[173],"had":[174,187,314],"0,":[175],"2":[178],"MSKCC":[179],"risk":[180],"factors":[181],"respectively.":[182],"Seventy-five":[183],"percent":[184],"distant":[188],"metastatic":[189],"at":[191,318,338],"study":[192],"entry":[193],"including":[194,236],"7":[195],"(16%)":[196],"liver,":[198],"3":[199,247],"(7%)":[200],"bone":[201],"14":[203],"(32%)":[204],"lung":[205],"metastases.":[206],"A":[207],"4":[210,234,249],"administered":[213],"(range,":[214],"1\u20136).":[215],"most":[217],"common":[218],"reasons":[219],"discontinuing":[221],"progressive":[224],"(27%)":[226],"(20%).":[229],"Eighteen":[230],"experienced":[232],"toxicities,":[235],"leukocytes":[237],"(n=5),":[238],"neutrophils":[239],"(n=18),":[240],"cardiac":[241,282],"arrest,":[242],"fatigue,":[243],"infection":[244,275],"neutropenia":[250,268,277],"(n=1":[251],"each).":[253],"died":[256,273],"from":[257,267,274],"5":[259],"toxicities":[260],"while":[261],"receiving":[262],"treatment:":[263],"one":[264],"death":[265],"other":[271],"without":[276],"following":[278],"sepsis":[279],"subsequent":[281],"arrest.":[283],"Response":[284],"information":[285],"available":[287],"39":[289],"There":[291],"been":[293],"complete":[295],"partial":[299],"responses":[300],"an":[302],"overall":[303],"rate":[305],"28%":[307],"(90%":[308],"CI:":[309],"[17%,":[310],"42%]).":[311],"Eleven":[312],"stable":[315],"least":[319],"weeks.":[321],"Conclusions:":[322],"Pemetrexed/gemcitabine":[323],"modest":[325],"patients":[328],"previously":[330],"urothelium,":[336],"but":[337],"cost":[340],"significant":[342],"toxicity.":[343],"[Table:":[344],"see":[345],"text]":[346]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-04-07T00:00:00"}